Over the past 5 years, AI and ML have advanced significantly in the pharmaceutical industry. We explored Generative AI, like ChatGPT, for mining drug development pipeline information. Our whitepaper documents the state-of-the-art and assesses AI’s readiness for such tasks, using Foghorn Therapeutics as a case study.
Generative AI : ChatGPT Experiments Read More »
Recently, the struggles of Enamine, a Ukrainian chemicals company, brought back some memories of growing up in war zones.
Approximately one-third of Ukrainians have evacuated, and another third are internally displaced.We stand with Ukrainians fighting for self-determination, the Russian free press, and protesters. We support aid workers managing the refugee crisis.
Making A Difference Read More »
This Thursday marked 103 years since the end of the The War to End All Wars. In a very real sense though, it also marks the beginning of a war that continues to this day. A war, that until a few years ago, I didn’t really realise we were still fighting.
Remembrance Day 2021 Read More »
Whether you’re in the lab running an experiment, taking that morning jog around the mesa as your experiment runs, or making the drive into work, there are always lots of opportunities to stay up to date with the latest news from the biotech industry. Here’s what we’ve been listening to lately: TWIV: This Week In
What’s on Our Podcast Playlist? Read More »
I recently found myself catching up on tweets, and I came across this repost by Michael Gilman, CEO of Arrakis Therapeutics, and I was reminded that over the past 20 years we’ve seen an explosive redefinition of the edges of druggable space. The nucleus of that explosion was the human genome project. In my own
Expanding Druggable Space Read More »
A Johns Hopkins article about creating an in-house coronavirus test reminded me of a project at the University of Houston, where we developed a pathogen-identifying technology. This technology, now feasible with modern computing, aimed to quickly identify pathogens without isolation, potentially saving lives.
Finding the Genomic Signatures of Pathogens Read More »
Partnering events like BIO, JP Morgan, the CLSA Pharma Partnering Day, and many others are critical opportunities for getting your message out to potential partners and investors. Learn how Pharm2Market can help.
Preparing for Partnering Events Read More »
Recently we’ve been interviewing biotech investors to better understand the factors that influence an investment decision. Find out what we learned.
Common Mistakes Biotech Entrepreneurs Make – The Investor Perspective Read More »
We’ve added PitchBook and RocketReach to Pharm2Market to make it easier for entrepreneurs to connect with investors, and for resource companies to find new customer contacts.
Pharm2Market June Newsletter Read More »
Things have been pretty busy this month at Pharm2Market as we continue to grow our business intelligence service in the communities we serve.
Pharm2Market April Newsletter Read More »
